Genome-Wide Association Study Identifies Risk Loci for Cluster Headache.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
08 2021
Historique:
revised: 26 06 2021
received: 25 09 2020
accepted: 28 06 2021
pubmed: 30 6 2021
medline: 9 11 2021
entrez: 29 6 2021
Statut: ppublish

Résumé

This study was undertaken to identify susceptibility loci for cluster headache and obtain insights into relevant disease pathways. We carried out a genome-wide association study, where 852 UK and 591 Swedish cluster headache cases were compared with 5,614 and 1,134 controls, respectively. Following quality control and imputation, single variant association testing was conducted using a logistic mixed model for each cohort. The 2 cohorts were subsequently combined in a merged analysis. Downstream analyses, such as gene-set enrichment, functional variant annotation, prediction and pathway analyses, were performed. Initial independent analysis identified 2 replicable cluster headache susceptibility loci on chromosome 2. A merged analysis identified an additional locus on chromosome 1 and confirmed a locus significant in the UK analysis on chromosome 6, which overlaps with a previously known migraine locus. The lead single nucleotide polymorphisms were rs113658130 (p = 1.92 × 10 We identified and replicated several genome-wide significant associations supporting a genetic predisposition in cluster headache in a genome-wide association study involving 1,443 cases. Replication in larger independent cohorts combined with comprehensive phenotyping, in relation to, for example, treatment response and cluster headache subtypes, could provide unprecedented insights into genotype-phenotype correlations and the pathophysiological pathways underlying cluster headache. ANN NEUROL 2021;90:193-202.

Identifiants

pubmed: 34184781
doi: 10.1002/ana.26150
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-202

Subventions

Organisme : Brain Research UK
Organisme : Health education England
Organisme : Hjärnfonden
ID : FO2018-0008
Organisme : Karolinska Institutet Research Funds
ID : 2018-01738
Organisme : Vetenskapsrådet
ID : 2017-01096
Organisme : Wellcome Trust and strategic award
ID : WT093205 MA
Organisme : Wellcome Trust and strategic award
ID : WT104033AIA
Organisme : Wellcome Trust Institutional Strategic Support Fund
ID : 204809/Z/16/Z
Organisme : University of London
Organisme : Brain Foundation
Organisme : Swedish Research Council
Organisme : Medical Research Council
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Fischera M, Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia 2008;28:614-618.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia 2018;38:629-808.
Vollesen AL, Benemei S, Cortese F, et al. Migraine and cluster headache-the common link. J Headache Pain 2018;19:89.
Steinberg A, Fourier C, Ran C, et al. Cluster headache-clinical pattern and a new severity scale in a Swedish cohort. Cephalalgia 2018;38:1286-1295.
Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002;58:354-361.
Gibson KF, Dos Santos A, Lund N, et al. Genetics of cluster headache. Cephalalgia 2019;39:1298-1312.
Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 2002;1:251-257.
May A, Ashburner J, Buchel C, et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999;5:836-838.
Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 2016;48:856-866.
Bacchelli E, Cainazzo MM, Cameli C, et al. A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants. J Headache Pain 2016;17:114.
Ran C, Fourier C, Michalska JM, et al. Screening of genetic variants in ADCYAP1R1, MME and 14q21 in a Swedish cluster headache cohort. J Headache Pain 2017;18:88.
Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
Pedersen BS, Quinlan AR. Who's who? Detecting and resolving sample anomalies in human DNA sequencing studies with Peddy. Am J Hum Genet 2017;100:406-413.
McCarthy S, Das S, Kretzschmar W, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 2016;48:1279-1283.
Loh P-R, Palamara PF, Price AL. Fast and accurate long-range phasing in a UKbiobank cohort. Nat Genet 2016;48:811-816.
Das S, Forer L, Schönherr S, et al. Next-generation genotype imputation service and methods. Nat Genet 2016;48:1284-1287.
Zhou W, Nielsen JB, Fritsche LG, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet 2018;50:1335-1341.
RStudio Team. RStudio: integrated development environment for R. Boston, MA: RStudio, 2015.
Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010;26:2336-2337.
Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun 2017;8:1826.
Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
McLaren W, Gil L, Hunt SE, et al. The Ensembl variant effect predictor. Genome Biol 2016;17:122.
Cooper GM, Stone EA, Asimenos G, et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 2005;15:901-913.
de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol 2015;11:e1004219.
Consortium GTe. The genotype-tissue expression (GTEx) project. Nat Genet 2013;45:580-585.
Kang HJ, Kawasawa YI, Cheng F, et al. Spatio-temporal transcriptome of the human brain. Nature 2011;478:483-489.
Zhang Y, Sloan SA, Clarke LE, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 2016;89:37-53.
Raudvere U, Kolberg L, Kuzmin I, et al. G:profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res 2019;47:W191-W198.
Consortium GO. The gene ontology (GO) database and informatics resource. Nucleic Acids Res 2004;32:D258-D261.
Kanehisa M, Sato Y, Kawashima M, et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2015;44:D457-D462.
Croft D, O'Kelly G, Wu G, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 2011;39:D691-D697.
Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 2014;10:e1004383.
Döcker D, Schubach M, Menzel M, et al. Further delineation of the SATB2 phenotype. Eur J Hum Genet 2014;22:1034-1039.
Huang Y, Song N-N, Lan W, et al. Expression of transcription factor Satb2 in adult mouse brain. Anat Rec (Hoboken) 2013;296:452-461.
Zhang Q, Huang Y, Zhang L, et al. Loss of Satb2 in the cortex and hippocampus leads to abnormal behaviors in mice. Front Mol Neurosci 2019;12:33.
Fourgeaud L, Través PG, Tufail Y, et al. TAM receptors regulate multiple features of microglial physiology. Nature 2016;532:240-244.
Walsh AD, Johnson LJ, Harvey AJ, et al. Identification and characterisation of cis-regulatory elements upstream of the human receptor tyrosine kinase gene MERTK. Brain Plast 2020;Preprint:1-14.;
Tongue AC. Clinical findings and common symptoms in retinitis pigmentosa. Am J Ophthalmol 1988;106:507-508.
Ma GZM, Stankovich J, Australia, et al. Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility. PLoS One 2011;6:e16964.
Chung W-S, Clarke LE, Wang GX, et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 2013;504:394-400.
Zhang Y, Zhang M, Wu J, et al. Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking. PLoS One 2012;7:e48587.
Zhao H, Alam A, Chen Q, et al. The role of microglia in the pathobiology of neuropathic pain development: what do we know? Br J Anaesth 2017;118:504-516.
Kobayashi K, Yamanaka H, Fukuoka T, et al. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci 2008;28:2892-2902.
Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012;74:691-705.
Chou K-H, Yang F-C, Fuh J-L, et al. Altered white matter microstructural connectivity in cluster headaches: a longitudinal diffusion tensor imaging study. Cephalalgia 2014;34:1040-1052.
Leone M, D'Amico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: a double- blind study versus placebo. Neurology 2000;54:1382-1385.
Liu Y, Lo Y-C, Qian L, et al. Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology 2011;60:373-380.
Chen PS, Wang CC, Bortner CD, et al. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 2007;149:203-212.
Oka T, Aou S, Hori T. Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Res 1994;656:236-244.
Cummings CT, Deryckere D, Earp HS, Graham DK. Molecular pathways: MERTK signaling in cancer. Clin Cancer Res 2013;19:5275-5280.
The ENCODE (ENCyclopedia of DNA elements) project. Science 2004;306:636-640.
Mitsikostas DD, Knight YE, Lasalandra M, et al. Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? J Headache Pain 2011;12:411-417.
Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191.
Winkler TW, Day FR, Croteau-Chonka DC, et al. Quality control and conduct of genome-wide association meta-analyses. Nat Protoc 2014;9:1192-1212.

Auteurs

Emer O'Connor (E)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.
Neurogenetics Laboratory, Institute of Neurology, University College London, London, UK.
Headache and Facial Pain Group, University College London Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.

Carmen Fourier (C)

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Caroline Ran (C)

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Prasanth Sivakumar (P)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Franziska Liesecke (F)

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Laura Southgate (L)

Molecular and Clinical Sciences Research Institute, St George's, University of London, London, UK.
Department of Medical & Molecular Genetics, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Aster V E Harder (AVE)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Lisanne S Vijfhuizen (LS)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Janice Yip (J)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Nicola Giffin (N)

Neurology Department, Royal United Hospital, Bath, UK.

Nicholas Silver (N)

Walton Centre, Liverpool, UK.

Fayyaz Ahmed (F)

Department of Neurology, Hull Royal Infirmary, Hull, UK.

Isabel C Hostettler (IC)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Brendan Davies (B)

Department of Neurology, University Hospital North Midlands National Health Service Trust, Stoke-on-Trent, UK.

M Zameel Cader (MZ)

Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

Benjamin S Simpson (BS)

Division of Surgery and Interventional Science, University College London, London, UK.

Roisin Sullivan (R)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Stephanie Efthymiou (S)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Joycee Adebimpe (J)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Olivia Quinn (O)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Ciaran Campbell (C)

Science Foundation Ireland FutureNeuro Research Centre, Royal College of Surgeons, Ireland School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland Dublin, Dublin, Ireland.

Gianpiero L Cavalleri (GL)

Science Foundation Ireland FutureNeuro Research Centre, Royal College of Surgeons, Ireland School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland Dublin, Dublin, Ireland.

Michail Vikelis (M)

Glyfada Headache Clinic, Glyfada, Greece.

Tim Kelderman (T)

Department of Neurology, Ghent University Hospital, Ghent, Belgium.

Koen Paemeleire (K)

Department of Neurology, Ghent University Hospital, Ghent, Belgium.

Emer Kilbride (E)

University College Hospital London, London, UK.

Lou Grangeon (L)

Headache and Facial Pain Group, University College London Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.
Department of Neurology, Rouen University Hospital, Rouen, France.

Susie Lagrata (S)

Headache and Facial Pain Group, University College London Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.

Daisuke Danno (D)

Headache and Facial Pain Group, University College London Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.

Richard Trembath (R)

Department of Medical & Molecular Genetics, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Nicholas W Wood (NW)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.
Neurogenetics Laboratory, Institute of Neurology, University College London, London, UK.

Ingrid Kockum (I)

Division of Neurology, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Bendik S Winsvold (BS)

Department of Research, Innovation, and Education, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
K. G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Neurology, Oslo University Hospital, Oslo, Norway.

Anna Steinberg (A)

Division of Neurology, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Christina Sjöstrand (C)

Division of Neurology, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Elisabet Waldenlind (E)

Division of Neurology, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Jana Vandrovcova (J)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Henry Houlden (H)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Manjit Matharu (M)

Headache and Facial Pain Group, University College London Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.

Andrea Carmine Belin (AC)

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH